<DOC>
	<DOCNO>NCT00532428</DOCNO>
	<brief_summary>This cross-sectional study determine , via iliac crest bone biopsy , effect long-term treatment raloxifene histomorphometry bone quality patient participate Continuing Outcomes Relevant Evista Study .</brief_summary>
	<brief_title>Long Term Effects Raloxifene Treatment Bone Quality</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Raloxifene Hydrochloride</mesh_term>
	<criteria>Have complete CORE protocol within 3 month ( 90 day ) prior study entry enrollment . Have take randomize study material least 7 year since enrollment MORE protocol . If patient opt receive randomize study material period 6 month point either MORE CORE protocol , period must occur entirety Visit 3 CORE protocol . Overall , least 75 % compliant randomize study material MORE CORE protocol . Have allergy intolerance tetracycline hydrochloride would preclude administration conjunction bone biopsy procedure . If patient allergic tetracycline , exclusion may waive sponsor different tetracycline patient allergic may use . Have undergone two previous transiliac bone biopsy ( one iliac crest ) . Patients one previous transiliac bone biopsy eligible provide new sample obtain contralateral iliac crest . In opinion investigator , medical anatomical condition potentially could put patient additional risk adverse event due procedure ( example , coagulation abnormality , extreme obesity , etc. ) . Have history bone metabolic disease , Paget 's disease , renal osteodystrophy , osteomalacia , secondary cause osteoporosis , hyperparathyroidism ( uncorrected ) , intestinal malabsorption . Have history malignant neoplasms prior 5 year , exception superficial basal cell carcinoma squamous cell carcinoma skin definitively treat . If malignant neoplasm ever diagnose , patient must presently free disease .</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>